ClinicalTrials.gov
public full text
Public Domain
Single Ascending Dose Study of MSD-001 in Healthy Participants
The purpose of this Phase 1 single ascending dose (SAD) study is to evaluate the safety and tolerability, pharmacokinetics, and pharmacodynamic profile of MSD-001 when administered orally to healthy adult participants.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BSY001 After Single/Multiple Doses.#806182
- First in Human Study of EI-001 Monoclonal Antibody in Healthy Volunteers#1074698
- Quantifying MS Progression in the Era of Highly Effective Therapy: Trial Design Implications#261200
- First-in-human Study of M4076 in Advanced Solid Tumors (DDRiver Solid Tumors 410)#995506
- Single and Multiple Ascending Dose Study of NGM120 in Healthy Adult Subjects#908157
Record · ID 892031
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive